Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 111,992 |
|
|||||
| News | - | ||||||
| Day High | 17.145 | Low High |
|||||
| Day Low | 16.62 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kiniksa Pharmaceuticals Ltd | KNSA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.105 | -0.62% | 16.775 | 12:17:23 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 16.87 | 16.62 | 17.145 | 16.88 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,569 | 111,992 | $ 16.84 | $ 1,885,395 | - | 10.645 - 22.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:17:34 | 50 | $ 16.78 | USD |
Kiniksa Pharmaceuticals Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 595.24M | 35.41M | - | 270.26M | 14.08M | 0.40 | 42.27 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kiniksa Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KNSA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.71 | 17.71 | 16.62 | 17.17 | 331,986 | -0.935 | -5.28% |
| 1 Month | 20.03 | 20.32 | 16.62 | 18.36 | 342,270 | -3.26 | -16.25% |
| 3 Months | 18.47 | 22.10 | 16.62 | 19.51 | 363,530 | -1.70 | -9.18% |
| 6 Months | 16.64 | 22.10 | 14.12 | 18.16 | 423,248 | 0.135 | 0.81% |
| 1 Year | 11.70 | 22.10 | 10.645 | 17.11 | 432,828 | 5.08 | 43.38% |
| 3 Years | 15.39 | 22.10 | 7.36 | 14.23 | 391,906 | 1.39 | 9.00% |
| 5 Years | 16.36 | 33.00 | 5.01 | 15.29 | 352,699 | 0.415 | 2.54% |
Kiniksa Pharmaceuticals Description
| Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. |
